STEVEN MANLEY: Open Payments
NPI 1699112953 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 44 payments from 20 companies in 2025. Trend: 2023 $1,094 · 2024 $1,062 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $155 |
| PFIZER INC. | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $81 |
| Merck Sharp & Dohme LLC | 3 | $77 |
| UROGEN PHARMA, INC. | 2 | $71 |
| Janssen Biotech, Inc. | 2 | $63 |
| Antares Pharma, Inc. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $52 |
| TOLMAR, INC. | 2 | $50 |
Products named: Xtandi, ADSTILADRIN, Nubeqa, KEYTRUDA, ERLEADA, XYOSTED, JOURNAVX, LYNPARZA.
Industry payments across GA — which companies pay providers there.
